Top Solana and Shiba Inu Holders Are Racing To Remittix After Early Holders See Over 230% Gains
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
- Science
Gina Kolata
- 0
- 1 minute read
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
